Skip to content
Search

Latest Stories

Semenya 'made to suffer', says Indian gender-row sprinter

Indian gender-row sprinter Dutee Chand on Thursday (2) said Caster Semenya's court defeat over testosterone rules was "wrong", but backed the Olympic 800 metres champion to overcome the potentially far-reaching ruling.

Chand, who fought and won a long battle over her own hyperandrogenism, or elevated levels of male sex hormones, said she felt sorry for the South African star, whose career has been plagued by controversy.


"This is wrong. I feel sad for her, she has been made to suffer like me," Chand, 23, told AFP.

Chand, who was subjected to humiliating gender-testing as a teenager, was finally cleared to compete last year after winning a court appeal against International Association of Athletics Federations (IAAF) regulations.

Chand successfully challenged the IAAF's stance on hyperandrogenism, prompting the world governing body to change its rules to target only middle-distance events, arguing these were most affected by elevated testosterone.

But on Wednesday, the Court of Arbitration for Sport in Lausanne dismissed Semenya's appeal against the IAAF measures, triggering an angry response in South Africa.

The decision means that women with elevated testosterone will have to take suppressive treatment if they wish to compete as females in certain events.

To defend her title at the world championships in September, Semenya, 28, will now have to take medication, probably including birth control pills. She is now weighing an appeal.

Chand, who won 100m and 200m silver at last year's Asian Games, her first major event since returning to competition, was hopeful that Semenya's legal team will find a way to succeed.

"It was my legal team that handled her case. The team that fought my case, I handed them over to Caster Semenya," Chand said.

"I think she and her team will find a way out. She is an Olympic medallist and her country is behind her."

The CAS ruling raised several concerns about the IAAF regulations, calling them "discriminatory" and questioning their implementation, as well as the lack of evidence proving an advantage from higher testosterone levels.

"See this (the condition) is natural. To increase and decrease testosterones is not in our hand. Now medical scientists can guide her," said Chand.

"But she is not poor like me and is well known with a lot of money and resources," said Chand, who was born in rural poverty.

The court decision drew anger from officials and fans in South Africa, whose minister for women, Bathabile Dlamini, called it "the violation of her rights as human being".

Semenya, who won the 800m Olympic title in 2012 and 2016, vowed to "once again rise above and continue to inspire young women and athletes in South Africa and around the world".

More For You

ArcelorMittal green energy investment

The Luxembourg-based steel giant will develop combined solar, wind and battery storage facilities with a total capacity of 1GW

iStock

ArcelorMittal to double its green energy portfolio in India with nearly $1 billion investment

Highlights

  • $0.9 billion investment in solar, wind and battery storage projects to double renewable capacity to 2GW.
  • Three facilities planned for Amravati, Bikaner and Bachau, supplying clean power to AMNS India steelmaking operations.
  • Projects expected to reduce carbon emissions by 4 million tonnes annually, meeting 35 per cent of Hazira plant's electricity needs.

ArcelorMittal has announced plans to invest $0.9 billion in three major renewable energy projects across India, doubling its green energy portfolio in the country to 2 gigawatts.

The Luxembourg-based steel giant will develop combined solar, wind and battery storage facilities in Maharashtra, Rajasthan and Gujarat with a total capacity of 1GW.

Keep Reading Show less